Every SEC Form 3/4/5 on record for this filer (CIK 1189014) — 5 issuers, 131 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PRU | PRUDENTIAL FINANCIAL INC | Director | 2015-09-21 → 2026-06-15 | 57 | — |
| NBIX | NEUROCRINE BIOSCIENCES INC | Director | 2023-07-13 → 2026-05-29 | 6 | — |
| REGN | REGENERON PHARMACEUTICALS, INC. | Director | 2015-08-12 → 2026-01-06 | 18 | −$71M |
| SHW | SHERWIN WILLIAMS CO | Director | 2015-07-06 → 2025-04-07 | 50 | — |
| DBTX | Decibel Therapeutics, Inc. | Director · lapsed | 2021-02-11 → 2021-02-16 | 2 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| REGN | 2025-10-29 | Sell | 1,915 | $654.42 | $1M | 3,552 |
| REGN | 2025-10-29 | Sell | 100 | $655.10 | $65,510 | 3,452 |
| REGN | 2025-10-29 | Sell | 712 | $656.50 | $467,428 | 2,740 |
| REGN | 2025-10-29 | Sell | 388 | $657.29 | $255,029 | 2,352 |
4 of 5 issuers are covered and open a security page; the rest are on file here only.